MAGE-3/Melan-A/gp100/NA17 vaccine

· University of Chicago

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAGE-3/Melan-A/gp100/NA17 vaccine, covering 2013-09-05 to 2013-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma [Phase 2]